NCT06010693 A Study of Daridorexant in Chinese Patients With Insomnia Disorder Status COMPLETED Phase PHASE3
NCT06009874 Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI Status RECRUITING Phase NA
NCT06009653 Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity Status WITHDRAWN Phase PHASE4
NCT06008756 Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06008652 A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT06008197 A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients Status RECRUITING Phase PHASE3
NCT06007781 Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants Status COMPLETED Phase PHASE1
NCT06007651 A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD) Status TERMINATED Phase PHASE1
NCT06007638 A Single and Multiple Ascending Dose Study of LY3876602 in Healthy Participants Status COMPLETED Phase PHASE1
NCT06007235 CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa Status RECRUITING Phase NA
NCT06006559 A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever Status RECRUITING Phase PHASE2
NCT06005792 Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis Status TERMINATED Phase PHASE1
NCT06005428 Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Status TERMINATED Phase PHASE2
NCT06005259 Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) Status NOT_YET_RECRUITING Phase PHASE4
NCT06005012 Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM Status UNKNOWN Phase PHASE2
NCT06004921 A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AB801 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT06004856 Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia Status RECRUITING Phase PHASE3